Form 4 for CVS CVS Health
Accepted 2023-08-04 00:00:00 ET · period of report 2023-08-03 · accession 0001127602-23-022036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-04 | 2023-08-03 | CVS | Clark James David | SVP, Cont, Chief Acct Off | S - Sale | $74.92 | -25.8K | 4,698 | -85% | -$1.93M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-03 | S | D | 2,631.26 | $74.79 | 27,826 | D | — | — | (F1) Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share. |
| 2 | Common | Common Stock | 2023-08-03 | S | D | 23,128 | $74.94 | 4,698 | D | — | — | (F2) Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share. |